"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to DYN. [ FAQ on what and how to ask] For non-DYN questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. John G. Cox M.B.A.
Headquarter: 1560 Trapelo Road, Waltham, MA, United States, 02451
Industry: Biotechnology, Investment Track: RNA-based therapy, Employees: 258
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
My Watchlist
